Determination of COVID-19 PCR positivity and mutation status in coronaVac vaccinated individuals in TurkeyArticle Published on 2022-06-012023-07-10 Journal: Turkish Journal of Medical Sciences [Category] COVID19(2023년), [키워드] CoronaVac vaccine SARSCoV-2 Sinovac Turkey variant virus [DOI] 10.55730/1300-0144.5344
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort studyObservational Study Published on 2022-06-012022-10-04 Journal: The Lancet. Global health [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI adjusted Administered Admission Antigen approach AZD1222 BNT162b2 booster booster dose Booster vaccine calculated Cohort Complete confounders CoronaVac country COVID-19 COVID-19 vaccine Cox model death dose doses Effectiveness eligible evaluated Evidence excluded hazard ratios Heterologous homologous homologous or heterologous hospitalisation ICU admission inactivated individual individuals initiative intensive care laboratory-confirmed outcome outcomes Oxford-AstraZeneca participant Pfizer-BioNTech Policy Program prospective cohort study provide Regression model RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccines Science severe disease Sinovac stratified study period Support survival symptomatic the vaccine vaccination vaccination schedule Vaccine vaccine dose [DOI] 10.1016/S2214-109X(22)00112-7 PMC 바로가기 [Article Type] Observational Study
Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine비활성화된 SARS-CoV-2 백신으로 면역된 건강한 개인의 면역 반응과 관련된 단백질 및 대사체 서명Article Published on 2022-05-242022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] Activation Adaptive immune response adaptive immune system affected Amino acid amino acids Analysis applied approach Arm Biosynthesis Cohort complement Complement activation CoronaVac COVID-19 dose driving glycine help highlight host response humoral Humoral response identify IgM/IgG immune immune response immune signature Immunity immunization immunized Inactivated vaccine individual innate immune system Interaction mechanism metabolic pathway metabolic pathways metabolism metabolite metabolites metabolomics molecular molecular mechanism multifactorial network Phenylalanine proteomics response SARS-CoV-2 SARS-COV-2 infection Serine shown signature Sinovac specific IgM Systems biology TCA cycle threonine Tryptophan tyrosine utility vaccination Volunteer [DOI] 10.3389/fimmu.2022.848961 PMC 바로가기 [Article Type] Article
Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature코로나19 백신 접종 후 밀러 피셔 증후군: 증례 보고 및 문헌 검토Review Published on 2022-05-202022-09-11 Journal: Medicine [Category] 변종, [키워드] adverse effect albuminocytologic dissociation Analysis areflexia Ascending paralysis association Ataxia Blood cerebrospinal fluid Complete Complication coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccinations diagnosed Diagnosis Diplopia discharge ENhance febrile febrile illness first dose Fisher syndrome Guillain-barrè syndrome hypertensive immunoglobulins Infection intravenous latency lower limb lower limbs male management Miller Miller fisher syndrome moderate Nerve conduction ophthalmoplegia paralysis pathophysiology Physical examination Physiotherapy pregabalin radiological reduced reported required Research resolution of symptom routine Sinovac Socioeconomic Factors the patient triggers vaccination Vaccinations variant viral infection viral infections [DOI] 10.1097/MD.0000000000029333 PMC 바로가기 [Article Type] Review
Role of COVID-19 Vaccines in SARS-CoV-2 VariantsSARS-CoV-2 변이체에서 COVID-19 백신의 역할Review Published on 2022-05-202022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 affected Antigen approach AstraZeneca caused coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 vaccine COVID-19 vaccines Delta delta variant Effectiveness effort Emergency Health Mutation omicron Omicron variant Pathogenesis pathogenesis of SARS-CoV-2 Pfizer role SARS-CoV-2 SARS-CoV-2 variants Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Sinovac Treatment Vaccine Vaccines variant variants WHO [DOI] 10.3389/fimmu.2022.898192 PMC 바로가기 [Article Type] Review
An overview on inactivated and live-attenuated SARS-CoV-2 vaccines불활성화 및 약독화 SARS-CoV-2 백신에 대한 개요Review Published on 2022-05-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse effects antigenic attenuated vaccine benefit Bharat Cell culture Cellular immune response China clinical trials component components coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine deaths effective Efficiency Features followed by Health Organization humoral Humoral and cellular immune responses immune responses inactivated Inactivated vaccine Infection landscape Phase 3 produced producing Record report review Safe SARS-CoV-2 SARS-CoV-2 vaccine severe acute respiratory syndrome Coronavirus similarity Sinopharm Sinovac storage the vaccine Transport trials Vaccine vaccine candidate vaccine platform Vaccines virion virus particle WHO World Health Organization worldwide pandemic Wuhan [DOI] 10.1002/jcla.24418 PMC 바로가기 [Article Type] Review
Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population터키 노인 인구에서 SARS-CoV-2 비활성화 백신(CoronaVac)에 대한 항체 반응Article Published on 2022-05-012022-09-11 Journal: Age and Ageing [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] affecting Anti-spike anti-Spike IgG Antibody Response association best Charlson Comorbidity Index clinical Comorbidity Comprehensive CoronaVac COVID-19 vaccine defined Factor frailty geriatric assessment group IgG antibodies IgG antibody Inactivated vaccine individual Infection influence knowledge neutralising neutralising antibody Older older people Patient patients performed Prevalence response duration SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike-specific SARS-CoV-2 spike-specific IgG antibodies scale second dose seronegative seropositive Seropositivity significantly higher Sinovac specific IgG antibodies the antibody response the vaccine three group three groups U/mL vaccination [DOI] 10.1093/ageing/afac088 PMC 바로가기 [Article Type] Article
Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2SARS-CoV-2에 대한 새로운 억제제를 찾기 위한 in silico 연구의 의미Review Published on 2022-05-012022-09-11 Journal: Archiv der Pharmazie [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ad26.COV2.S affected Antiviral antiviral drug antiviral phytoconstituents antiviral properties antiviral property approved AstraZeneca AZD1222 BBIBP-CorV Bharat BNT162b2 carried caused combating Corona CoronaVac coronavirus country COVID-19 COVID-19 infection database disease drug Drug administration effective effective vaccine Emergency use food Health Organization in silico in silico screening in vitro in vivo India individual inhibitor inhibitors inhibitors of SARS-CoV-2 janssen library Ligand Medicine Medicines Moderna molecular molecular docking mRNA mRNA-1273 Mutation occurred pandemic pandemic disease performed Pfizer/BioNTech plant plants PubChem Remdesivir researcher SARS-CoV-2 severe acute respiratory syndrome Coronavirus silico studies Sinopharm Sinovac Spread targets Treatment treatment of COVID-19 Vaccine Vaccines variants of SARS-CoV-2 Veklury WHO World Health Organization Wuhan Wuhan, China Zinc [DOI] 10.1002/ardp.202100360 PMC 바로가기 [Article Type] Review
Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey터키에서 입원 환자의 Sinovac 예방 접종과 COVID-19 질병의 경과Article Published on 2022-05-012022-09-11 Journal: Annals of Saudi medicine [Category] COVID19(2023년), SARS, 변종, [키워드] Administered admitted to ICU affected age Alpha variant Characteristics cohort study comorbid disease comorbid diseases Comorbidities conflict conflict of interest Course COVID-19 COVID-19 disease demographic demographic characteristics diabetes Diabetes Mellitus diagnosis of COVID-19 disease dose Efficacy faster health institution hospital Hospitalization Hospitalized hospitalized patient hypertension include information intensive care intensive care unit MOST outcome Patient patients patients older Pediatric patients pregnant Sample SARS-CoV-2 SARS-CoV-2 variants second dose single-center Sinovac Spread Tertiary the disease the patient transmission rate Turkey vaccination vaccination rate Vaccine variant virus younger patient younger patients [DOI] 10.5144/0256-4947.2022.147 PMC 바로가기 [Article Type] Article
COVID-19 Mortality and Vaccine Coverage – Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022COVID-19 사망률 및 백신 적용 범위 - 홍콩 특별 행정구, 중국, 2022년 1월 6일 - 2022년 3월 21일Article Published on 2022-04-152022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] age analyzed available data BNT162b2 booster booster dose cause caused China Cluster Coverage COVID-19 COVID-19 case COVID-19 cases COVID-19 mortality COVID-19 outbreak COVID-19 pandemic COVID-19 vaccine death declined Department dose doses driven by help high mortality highest Hong Kong identify inactivated Mortality mRNA vaccine occurred omicron Omicron variant overall mortality peaked Pfizer-BioNTech Prevent proportion recipient recipients Region reported resulting risk Sinovac vaccination Vaccine vaccine dose variant of SARS-CoV-2 virus [DOI] 10.15585/mmwr.mm7115e1 PMC 바로가기 [Article Type] Article